HS patients carry higher risk for systemic lupus erythematosus

29 July, 2020 12:23

Biologics in HS – a growing armamentarium

29 July, 2020 12:21

Proton pump inhibitor use tied to childhood asthma

Journal

JAMA Pediatrics

8 February, 2021 23:02

Benralizumab improves health-related quality of life in severe eosinophilic asthma

Journal

Lancet Respiratory Medicine

15 January, 2021 16:14

Screen COPD patients with worsening lung function for pulmonary embolism?

Journal

JAMA

5 January, 2021 19:28

Disinfecting during pandemic puts asthmatics at risk

Journal

Journal of Allergy and Clinical Immunology

4 January, 2021 23:36

Asthma inhaler sensors improve pediatric asthma control

Journal

Pediatrics

24 December, 2020 22:28

Halting asthma medication for pregnancy tied to adverse perinatal outcomes

9 December, 2020 23:01

New asthma guidelines advise single maintenance and reliever therapy

Journal

JAMA

7 December, 2020 14:35

Children with exercise-induced respiratory symptoms may get conflicting diagnoses

Journal

Pediatric Pulmonology

24 November, 2020 21:19

Vitamin D supplement improves asthma control in adults with deficiency

Journal

Thorax

23 November, 2020 17:45

Anti-IL-5 biologics effective for up to two years in severe asthma, but residual disease remains

Journal

Journal of Allergy and Clinical Immunology in Practice

29 October, 2020 22:45

The role of chronic symptoms as early biomarkers of COPD development

Presented By

Dr James Allinson, Imperial College London, UK

Conference

ERS 2020

29 October, 2020 18:29

Urgent call for studies in COPD patients aged 40-60 years

Presented By

Prof. Wisia Wedzicha , Imperial College London, UK

Conference

ERS 2020

29 October, 2020 18:25

Nasal high-flow therapy: a novel treatment option for hypercapnic COPD patients

Presented By

Dr Jens Bräunlich, Kliniken Aurich-Emden-Norden, Germany

Conference

ERS 2020

29 October, 2020 18:10

Exacerbation history is a reliable predictor of future exacerbations

Presented By

Prof. Claus Vogelmeier, Philipps University of Marburg, Germany

Trial

Cohort study, AvoidEx

Conference

ERS 2020

29 October, 2020 18:07

Singing training effective as physical rehabilitation in COPD

Presented By

Prof. Uffe Bødtger, Nætved Hospital, Denmark

Conference

ERS 2020

29 October, 2020 18:02

Mild asthma: A fundamental change in management

Presented By

Prof. Roland Buhl, Johannes Gutenberg University of Mainz, Germany

Conference

ERS 2020

29 October, 2020 17:55

Dupilumab shows long-term efficacy in asthma patients

Presented By

Dr Michael Wechsler, Prof. Chris Brightling

Trial

LIBERTY ASTHMA TRAVERSE, LUSTER

Conference

ERS 2020

29 October, 2020 17:47

Severe asthma: Oral corticosteroids maintenance therapy associated with toxicity

Presented By

Prof. Njira Lugogo, University of Michigan, USA

Trial

CHRONICLE

Conference

ERS 2020

29 October, 2020 17:42

First-in-class tyrosine kinase inhibitor shows promise in severe asthma

Presented By

Prof. Pascal Chanez, Aix-Marseille Université, France

Conference

ERS 2020

29 October, 2020 17:39

Predicting individual effectiveness of biologics in severe asthma

Presented By

Prof. Celeste Porsbjerg, Bispebjerg-Frederiksberg University Hospital, Denmark

Conference

ERS 2020

29 October, 2020 17:34

Current prediction tools underestimate exacerbation risk of severe COPD patients

Presented By

Mr Spencer Keene, Maastricht University, the Netherlands

Trial

ECLIPSE

Conference

ERS 2020

29 October, 2020 16:57

IL-5 antagonist showed efficacy in chronic rhinosinusitis with nasal polyps

Presented By

Dr Claire Hopkins, Guy’s and St Thomas Hospital and King’s College London, UK

Trial

Phase 3, SYNAPSE

Conference

ERS 2020

29 October, 2020 16:42

Treatment according to genotype: The future of asthma therapy?

Presented By

Dr Tom Ruffles, Brighton & Sussex Medical School, UK

Conference

ERS 2020

29 October, 2020 15:49

Oral cannabinoid drugs may worsen COPD outcomes

Journal

Thorax

27 October, 2020 16:21

Asthma rescue with budesonide-formoterol cuts short-term flare risk

Journal

Lancet Respiratory Medicine

9 October, 2020 17:19

For COPD with nocturnal hypoxemia, nighttime oxygen has no survival benefit

Journal

New England Journal of Medicine

16 September, 2020 23:00

Bronchitis in childhood tied to worse lung health in adulthood

Conference

ERS 2020

11 September, 2020 23:03

AstraZeneca’s asthma drug succeeds late-stage nasal polyposis study

10 September, 2020 15:56

Limited evidence supports escalation of therapy for acute asthma exacerbations in kids

Journal

Cochrane Database of Systematic Reviews

4 September, 2020 19:50

Dactolisib Phase 2b Clinical Trial Data Shows Reduction of Respiratory Tract Infections in Senior Asthma Patients

21 May, 2019 11:16

Endoscopic treatment of asthma

24 December, 2018 14:35

Late-breaking biologics

24 December, 2018 14:29

From clinical, anatomical, pathophysiological, and inflammatory subsets to molecular pathways

24 December, 2018 14:25

Severe atopic eczema tied to higher risk of premature death

Journal

Journal of Allergy and Clinical Immunology

28 January, 2021 16:09

Meaningful sleep improvement with IL-13 inhibition

Presented By

Prof. Jonathan Silverberg, George Washington University, USA

Trial

Phase 3, ECZTRA

Conference

EADV 2020

17 December, 2020 14:33

Baricitinib in AD: Efficacy paired with consistent long-term results

Presented By

Prof. Jonathan Silverberg , George Washington University, USA

Trial

Phase 3, BREEZE-AD3

Conference

EADV 2020

17 December, 2020 14:31

Topical JAK inhibition: a novel treatment option for patients with mild-to-moderate AD

Presented By

Prof. Megan Landis, University of Louisville School of Medicine, USA

Trial

Phase 2

Conference

EADV 2020

17 December, 2020 14:22

Oral JAK 1 inhibitor leads to fast itch relieve and remarkable skin clearance in AD

Presented By

Prof. Emma Guttman-Yassky, Icahn School of Medicine at Mount Sinai, USA

Trial

Phase 3, Measure Up

Conference

EADV 2020

17 December, 2020 13:24

Effects IL-13 blocker improves with longer treatment duration

Presented By

Prof. Eric Simpson, Oregon Health & Science University, USA

Trial

Phase 3, ECZTRA

Conference

EADV 2020

17 December, 2020 12:37

Baricitinib plus corticosteroids effectively treats atopic dermatitis

Journal

JAMA Dermatology

9 October, 2020 23:27

Baricitinib beneficial in head and neck AD

Presented By

Dr Eric Simpson, Oregon Health and Science University, USA

Trial

Phase 3, BREEZE-AD1 and BREEZE-AD2

Conference

AAD 2020

19 August, 2020 07:23

Good response and pruritus reduction in AD with novel selective JAK1 inhibitor

Presented By

Dr Melinda Gooderham

Trial

JADE MONO-2

Conference

AAD 2020

6 August, 2020 07:08

IL-13 blocker tralokinumab effective in AD

Presented By

Prof. Eric Simpson

Trial

ECZTRA

Conference

AAD 2020

6 August, 2020 07:06

Tape stripping – a painless way to distinguish AD and psoriasis?

Presented By

Dr Robert Bissonnette, Innovaderm Research, Canada

Conference

AAD 2020

6 August, 2020 07:05

IL-4/IL-13 blocker dupilumab effective in children with severe AD

Presented By

Prof. Amy S. Paller, Northwestern University Feinberg School of Medicine, USA

Trial

Phase 3, LIBERTY AD PEDS

Conference

AAD 2020

6 August, 2020 07:04

Better compliance in AD skin care with novel emollient stick

Conference

AAD 2020

6 August, 2020 06:37

Baricitinib beneficial in head and neck AD

29 July, 2020 12:39

Better compliance in AD skin care with novel emollient stick

29 July, 2020 12:35

IL-4/IL-13 blocker dupilumab effective in children with severe AD

29 July, 2020 11:14

Tape stripping – a painless way to distinguish AD and psoriasis?

29 July, 2020 11:06

IL-13 blocker tralokinumab effective in AD

29 July, 2020 11:01

How to manage conjunctivitis in AD patients treated with a biologic

Expert

Prof. Tilo Biedermann, Helmholtz Center Munich, Germany

Conference

EADV 2019

9 December, 2019 16:01

Biologics: increasingly used in paediatric dermatology

Expert

Prof. Marieke Seyger, Radboud University Nijmegen, the Netherlands

Conference

EADV 2019

9 December, 2019 15:16

Cutaneous adverse events due to EGFR inhibitors

Expert

Dr Pietro Sollena, University of the Sacred Heart in Rome, Italy

Conference

WCD 2019

26 August, 2019 20:44

Living in the golden age of psoriasis and atopic dermatitis therapies

Expert

Dr Erik Joseph Stratman, Marshfield Clinic, Marshfield

Conference

AAD 2018

21 December, 2018 16:46

Just one drink a day can raise risk of developing atrial fibrillation

Journal

European Heart Journal

13 January, 2021 23:07

Left atrial appendage occlusion tied to less afib bleeding, mortality vs DOACs

Journal

JACC: Cardiovascular Interventions

12 January, 2021 23:20

Cryoablation Afib studies show better first-line outcomes than drug therapy

Journal

New England Journal of Medicine

Conference

AHA 2020

16 November, 2020 21:05

Rivaroxaban not inferior to warfarin for afib patients with artificial mitral valve

Journal

New England Journal of Medicine

Conference

AHA 2020

16 November, 2020 20:20

Direct oral anticoagulants may best vitamin K agonists for post-TAVR a-fib

Journal

JACC: Cardiovascular Interventions

12 November, 2020 16:28

Cryoballoon supplement to pulmonary-vein isolation curbs AF recurrence

Journal

JACC: Clinical Electrophysiology

6 November, 2020 21:14

2020 Atrial Fibrillation Guidelines

Presented By

Prof. Gerhard Hindricks, Heart Centre Leipzig, Germany

Conference

ESC 2020

5 November, 2020 14:05

Reduced cardiovascular outcomes with early rhythm control

Presented By

Prof. Paulus Kirchhof, University Heart & Vascular Center Hamburg, Germany

Trial

EAST-AFNET 4

Conference

ESC 2020

5 November, 2020 13:35

Drug initiation strategy not associated with increased use of oral anticoagulants

Presented By

Prof. Sean Pokorney , Duke University, USA

Trial

IMPACT-AFib trial

Conference

ESC 2020

5 November, 2020 13:07

Digoxin improves symptoms in stable patients with permanent AF

Presented By

Prof. Dipak Kotecha, University of Birmingham, UK

Trial

Phase 4, RATE-AF trial

Conference

ERS 2020

5 November, 2020 12:45

Lower risk of dementia with catheter ablation of atrial fibrillation

Journal

European Heart Journal

9 October, 2020 22:50

Numerous drugs can spawn a broad range of arrhythmias

Journal

Circulation

28 September, 2020 19:09

Opportunistic screening doesn’t find more AF cases

Journal

BMJ

25 September, 2020 21:53

Surgical bleeding risk most important determinant of bleeding outcomes

Presented By

Dr Kira MacDougall, Staten Island University Hospital, USA

Trial

PAUSE

Conference

ISTH 2020

8 September, 2020 16:27

Similar bleeding rates in patients with VTE and AF treated with DOACs

Presented By

Dr Farès Moustafa, CHU Clermont Ferrand, France

Conference

ISTH 2020

8 September, 2020 16:21

Factor V Leiden mutation linked to atrial fibrillation

Presented By

Erin Mathiesen Hald, UiT The Arctic University of Norway, Tromsø, Norway

Trial

Cohort study, Tromsø Study

Conference

ISTH 2020

8 September, 2020 16:08

Finding the sweet spot of anticoagulation in AF patients with ACS

Presented By

Prof. Renato D. Lopes, Duke University School of Medicine, USA

Trial

AUGUSTUS

Conference

ISTH 2020

8 September, 2020 14:59

Apixaban in AF patients with recent ACS/PCI: Drop aspirin after 30 days

Presented By

Prof. J. Alexander, Duke University, USA

Trial

AUGUSTUS

Conference

ACC 2020

8 September, 2020 14:06

Infusion of ethanol in the vein of Marshall for persistent AF

Presented By

Dr M. Valderrabano, Baylor College of Medicine, USA

Trial

VENUS

Conference

ACC 2020

8 September, 2020 12:40

Finding the sweet spot of anticoagulation in AF patients with ACS

4 September, 2020 22:26

Surgical bleeding risk most important determinant of bleeding outcomes

4 September, 2020 22:26

Similar bleeding rates in patients with VTE and AF treated with DOACs

4 September, 2020 22:26

Factor V Leiden mutation linked to atrial fibrillation

4 September, 2020 22:26

AF incidence up 3% annually in community-based study

Journal

JAMA Network Open

2 September, 2020 18:36

Atrial fibrillation after noncardiac surgery tied to higher stroke risk

Journal

JAMA

1 September, 2020 23:49

Factor V Leiden mutation linked to atrial fibrillation

14 July, 2020 10:52

Should breast density at age 40 guide mammography screening strategy?

Journal

Annals of Internal Medicine

9 February, 2021 00:27

Guidelines help individualize surveillance for older early-stage breast cancer survivors

Journal

JAMA Oncology

2 February, 2021 23:26

Breast cancer overtakes lung as most common cancer-WHO

2 February, 2021 18:08

Aspirin tied to improved breast, bladder cancer survival in older adults

Journal

JAMA Network Open

26 January, 2021 21:33

Margetuximab outperforms trastuzumab in advanced HER2-positive breast cancer

Journal

JAMA Oncology

25 January, 2021 23:23

Androgen receptor has potent anti-tumor activity in ER+ breast cancer

Journal

Nature Medicine

20 January, 2021 15:59

New tool helps predict chemotherapy toxicity in older women with early breast cancer

Journal

Journal of Clinical Oncology

14 January, 2021 22:00

Immune factors linked to poor survival in Black breast cancer patients, immunotherapy potentially helpful

12 January, 2021 23:11

MRI-based nomograms may predict lymph node metastasis, survival in early breast cancer

Journal

JAMA Network Open

16 December, 2020 23:48

Circulating-tumor-cell dynamics have prognostic value in metastatic breast cancer

Conference

2020 San Antonio Breast Cancer Symposium

15 December, 2020 20:34

Breast radiotherapy symptoms often under-recognized by providers

Conference

2020 San Antonio Breast Cancer Symposium

14 December, 2020 22:41

Mastectomy may raise risk of persistent use of opioids, sedative-hypnotics

Conference

2020 San Antonio Breast Cancer Symposium

11 December, 2020 17:18

Trade-offs to skipping radiotherapy after breast-conserving surgery in older women

Conference

2020 San Antonio Breast Cancer Symposium

10 December, 2020 16:37

Some older women with common breast cancer can skip adjuvant chemo

Conference

2020 San Antonio Breast Cancer Symposium

9 December, 2020 17:39

Tumor marker of bone metastasis in ER+ breast cancer identified

Journal

Bone

2 December, 2020 17:49

Fertility preservation tied to better reproductive outcomes after breast cancer

Journal

JAMA Oncology

1 December, 2020 22:35

New biomarker for breast-cancer outcomes

Journal

JAMA Network Open

27 November, 2020 19:42

Immediate breast reconstruction feasible following neoadjuvant chemo

Journal

JAMA Surgery

26 November, 2020 17:18

New assay platform enhances detection of circulating breast cancer cells

Journal

ACS Sensors

25 November, 2020 21:12

CDK4/6 inhibition in high-risk early breast cancer

Conference

ESMO 2020

25 November, 2020 16:20

Neoadjuvant treatment in patients with high-risk early breast cancer

Conference

ESMO 2020

25 November, 2020 16:19

Prognostic value of tumour infiltrating lymphocytes in young TNBC patients

Conference

ESMO 2020

25 November, 2020 16:16

Contradicting results for chemoimmunotherapy in metastatic TNBC

Conference

ESMO 2020

25 November, 2020 16:01

Second-line sacituzumab govitecan improves survival in metastatic TNBC

Conference

ESMO 2020

25 November, 2020 15:14

Breast density helps predict cancer-related lymphedema risk

Journal

JAMA Network Open

18 November, 2020 17:24

Risk of invasive breast cancer similar with family history of in situ or invasive disease

Journal

BMC Medicine

16 November, 2020 23:07

Image-guided biopsy may help some avoid breast-cancer surgery

Journal

JAMA Surgery

19 October, 2020 20:00

Gene signature predicts overall survival in women with breast cancer

Journal

JAMA Network Open

19 October, 2020 17:30

Textured implants linked to increased breast cancer recurrence risk

Journal

JAMA Surgery

13 October, 2020 23:27

Pfizer’s breast cancer drug Ibrance fails late-stage study

9 October, 2020 23:25

Study helps gauge long-term risks for women with DCIS by treatment

Conference

European Breast Cancer Conference 2020

7 October, 2020 21:04

Benign breast disease detected after baseline mammogram most apt to become cancer

Conference

European Breast Cancer Conference 2020

6 October, 2020 18:33

Genetic test spots high-risk invasive lobular carcinoma

Conference

European Breast Cancer Conference 2020

5 October, 2020 18:47

Interval breast cancers often more aggressive

Journal

JAMA Network Open

1 October, 2020 17:26

DCIS linked to higher breast cancer mortality, despite treatment

Journal

JAMA Network Open

24 September, 2020 23:35

Immunomedics drug Trodelvy extends survival in breast cancer patients

Conference

ESMO 2020

21 September, 2020 16:40

Advanced breast cancer: locoregional therapy does not improve OS

Presented By

Prof. Seema A. Khan, Feinberg School of Medicine, USA

Trial

Phase 3, E2108

Conference

ASCO 2020

8 September, 2020 09:50

T-DM1 does not improve safety or efficacy in HER-2 positive early breast cancer; favorable iDFS reported

Presented By

Prof. N. Harbeck, University of Munich, Germany

Trial

Phase 3, KAITLIN

Conference

ASCO 2020

8 September, 2020 09:40

Combination pembrolizumab/chemo improves PFS in metastatic TNBC

Presented By

Dr Javier Cortés, Vall d’Hebron Institute of Oncology, Spain & Catherine M. Kelly, Mater Misericordiae University Hospital, Ireland

Conference

ASCO 2020

8 September, 2020 09:32

Effect of veliparib with or without cisplatin in breast cancer: results of SWOG S1416

Presented By

Dr Priyanka Sharma, University of Kansas Medical Center, USA

Trial

Phase 2, SWOG 1416

Conference

ASCO 2020

8 September, 2020 09:30

PHOEBE, a phase 3 trial comparing pyrotinib and lapatinib in HER2-positive metastatic breast cancer

Presented By

Dr Binghe Xu, Peking Union Medical College, China

Trial

Phase 3, PHOEBE

Conference

ASCO 2020

8 September, 2020 09:10

BYLieve demonstrates efficacy of PIK3CA-directed treatment post CDK4/6-ihibition

Presented By

Prof. Hope S. Rugo, University of California San Francisco, CA, USA

Trial

Phase 2, BYLieve

Conference

ASCO 2020

8 September, 2020 09:00

Strategies emerge for chemotherapy de-escalation in HER2-positive breast cancer

Presented By

Dr Javier Cortés, Vall d’Hebron Institute of Oncology, Spain

Trial

Phase 2, PHERGAIN

Conference

ASCO 2020

8 September, 2020 08:50

BYLieve demonstrates efficacy of PIK3CA-directed treatment post CDK4/6-ihibition

31 July, 2020 11:02

PHOEBE, a phase 3 trial comparing pyrotinib and lapatinib in HER2-positive metastatic breast cancer

31 July, 2020 10:57

Strategies emerge for chemotherapy de-escalation in HER2-positive breast cancer

31 July, 2020 10:55

Effect of veliparib with or without cisplatin in breast cancer: results of SWOG S1416

31 July, 2020 10:53

Combination pembrolizumab/chemo improves PFS in metastatic TNBC

31 July, 2020 10:49

T-DM1 does not improve safety or efficacy in HER-2 positive early breast cancer; favorable iDFS reported

31 July, 2020 10:44

Advanced breast cancer: locoregional therapy does not improve OS

31 July, 2020 10:29

Positive effects of adding pertuzumab to trastuzumab + chemotherapy in operable HER2 breast cancer

Trial

APHINITY

Conference

SABCS 2019

13 February, 2020 23:13

Benzodiazepines given for ACS anxiety, pain may trigger posttraumatic stress symptoms

Journal

Journal of the American Heart Association

21 January, 2021 23:13

Calcium chloride during CABG curbs subsequent atrial fibrillation

Journal

Journal of the American College of Cardiology

18 January, 2021 19:08

Model to predict bleeding, thrombotic risks may help tailor PCI management

Journal

JAMA Cardiology

15 January, 2021 15:59

DASH-diet intervention might slow progression of nonobstructive coronary atherosclerosis

Journal

JACC: Cardiovascular Imaging

8 January, 2021 16:19

Higher levels of diet-derived antioxidants don’t protect against heart disease

Journal

Journal of the American College of Cardiology

4 January, 2021 20:11

CABG grafting risk thresholds differ between men and women

Journal

JAMA Cardiology

29 December, 2020 18:53

Study supports routine physiologic assessment to guide revascularization

Journal

JAMA

16 November, 2020 23:06

Trimetazidine after successful PCI not associated with fewer cardiac events

Presented By

Prof. Roberto Ferrari, University of Ferrara, Italy

Trial

ATPCI trial

Conference

ESC 2020

5 November, 2020 13:30

Low-dose colchicine reduces CV death and ischaemic events in coronary disease

Presented By

Dr Stefan Nidorf, Heart Care Western Australia, Australia

Trial

LoDoCo2 trial

Conference

ESC 2020

5 November, 2020 13:19

Rivaroxaban protects limbs and ischaemic events in CAD-PAD patients

Presented By

Prof. William Hiatt, University of Colorado, USA

Trial

VOYAGER PAD trial

Conference

ESC 2020

5 November, 2020 12:57

Reduced progression of coronary atherosclerosis with icosapent ethyl

Presented By

Prof. Matthew Budoff, Harbor-UCLA Medical Center, USA

Trial

EVAPORATE trial

Conference

ESC 2020

5 November, 2020 12:48

No difference in net adverse clinical events with clopidogrel, ticagrelor after PCI

Journal

JAMA

27 October, 2020 18:28

Mortality lower after coronary bypass surgery than after percutaneous interventions

Journal

JAMA Internal Medicine

21 October, 2020 17:07

Intravascular lithotripsy safely treats severely calcified coronary-artery disease

Journal

Journal of the American College of Cardiology

21 October, 2020 16:43

Fewer adverse events with ticagrelor monotherapy after 3 months DAPT

Presented By

Prof. Y.S. Jang, Yonsei University, South Korea

Trial

TICO

Conference

ACC 2020

8 September, 2020 15:29

TWILIGHT sub-study: same outcomes for diabetes patients

Presented By

Prof. D. Angiolillo, University of Florida - Jacksonville, USA

Trial

TWILIGHT, TWILIGHT-DM

Conference

ACC 2020

8 September, 2020 15:24

TWILIGHT sub-study: complex PCI patients

Presented By

Prof. G. Dangas, Icahn School of Medicine at Mount Sinai, USA

Trial

TWILIGHT

Conference

ACC 2020

8 September, 2020 15:20

Apixaban in AF patients with recent ACS/PCI: Drop aspirin after 30 days

Presented By

Prof. J. Alexander, Duke University, USA

Trial

AUGUSTUS

Conference

ACC 2020

8 September, 2020 14:06

Radial artery best for second bypass

Presented By

Prof. M. Gaudino, Weill Cornell Medicine, USA

Trial

RADIAL

Conference

ACC 2020

8 September, 2020 12:50

PCI and CABG are equal in left main CAD

Presented By

Dr D.W. Park, Asan Medical School, South Korea

Trial

PRECOMBAT

Conference

ACC 2020

8 September, 2020 12:45

TAILOR-PCI misses endpoint but still provides valuable insights

Presented By

Prof. N. Pereira, Mayo Clinic, USA

Trial

TAILOR-PCI

Conference

ACC 2020

7 September, 2020 23:16

Anti-CD20 therapy for lymphoma tied to worse COVID-19 outcomes

Conference

AACR 2020

9 February, 2021 00:06

NSAID users not at higher risk of death related to COVID-19

Journal

Annals of the Rheumatic Diseases

5 February, 2021 17:23

COVID-19 survival poor for hematopoietic stem cell transplant recipients

Journal

The Lancet Haematology

2 February, 2021 22:00

COVID has led to a drop in lung cancer diagnosis, more deaths

Conference

IASLC World Conference on Lung Cancer

2 February, 2021 00:23

COVID outcomes have improved over time in patients with rheumatic disease

Journal

The Lancet Rheumatology

26 January, 2021 22:42

COVID-19 vaccine recommended for all patients with IBD

Journal

Gut

26 January, 2021 20:52

Negative-pressure ventilator shows promise in new study

Journal

Anesthesia

25 January, 2021 22:40

COVID patients may suffer persistent skin problems

Journal

The Lancet Infectious Diseases

22 January, 2021 17:06

COVID-19 in patients with rheumatic disease: most report mild disease

Presented By

Dr Akhil Sood, University of Texas Medical Branch, USA

Conference

ACR 2020

18 January, 2021 10:57

Poor disease control: a risk factor for severe COVID-19

Presented By

Prof. Rebecca Grainger, University of Otago, New Zealand

Trial

COVID-19 Global Rheumatology Alliance Registry

Conference

ACR 2020

18 January, 2021 10:57

No heightened outcome risk for rheumatic patients with COVID-19

Presented By

Dr Naomi Serling-Boyd, Massachusetts General Hospital, USA

Conference

ACR 2020

18 January, 2021 10:56

Children with rheumatic disease have no greater risk of a COVID-19 infection

Presented By

Dr Jonathan S. Hausmann, Harvard Medical School and Boston Children’s Hospital, USA

Conference

ACR 2020

18 January, 2021 10:40

Cancer patients should get vaccine priority: experts

Journal

Cancer Discovery

21 December, 2020 23:47

Delaying cancer treatment during pandemic likely unnecessary

Journal

JAMA Oncology

21 December, 2020 23:16

COVID-19 far more deadly than seasonal flu, large study confirms

Journal

The Lancet Respiratory Medicine

18 December, 2020 23:45

Biologic psoriasis treatment and COVID-19 risk: Contradictory results

Presented By

Dr Anne-Claire Fougerousse; Dr Giovanni Damiani

Conference

EADV 2020

17 December, 2020 14:12

Much to be learned about COVID-19 and the skin

Presented By

Prof. Esther Freeman, Director of the COVID-19 Dermatology Registry

Trial

COVID-19 Dermatology Registry

Conference

EADV 2020

17 December, 2020 14:00

Shared pathways for COVID-19 and diabetes?

Conference

EASD 2020

14 December, 2020 12:32

COVID-19 and Cancer

Conference

ESMO 2020

25 November, 2020 16:22

Anti-cytokine therapy normalizes ACE2 expression in IBD, may protect against COVID-19

Journal

Gastroenterology - AGA

23 November, 2020 22:33

At-home cancer screening could thrive after the pandemic

Journal

Cancer

23 November, 2020 16:19

COVID-19: Continuing versus suspending ACE inhibitors and ARBs

Presented By

Prof. Renato Lopes, Duke University, USA

Trial

Phase 4, BRACE CORONA trial

Conference

ESC 2020

5 November, 2020 13:10

Risk factors for thromboembolism and bleeding in COVID-19: lessons from Wuhan

Presented By

Prof. Yutao Guo , Chinese PLA General Hospital, China

Conference

ESC 2020

5 November, 2020 12:27

The Yale COVID-19 Cardiovascular Registry

Presented By

Dr Manan Pareek, Yale University School of Medicine, USA

Trial

Yale COVID-19 Cardiovascular Registry

Conference

ESC 2020

5 November, 2020 12:24

COVID-19 treatments and the importance of randomised trials

Presented By

Prof. Martin Landray, University of Oxford, UK

Trial

RECOVERY

Conference

ESC 2020

5 November, 2020 11:49

COVID-19 infections: Bronchoscopy provides additional diagnostic certainty

Presented By

Dr Thomas Malfait, Ghent University Hospital, Belgium

Conference

ERS 2020

29 October, 2020 20:11

COVID-19 vaccines: An ongoing race

Presented By

Prof. George Karakiulakis, Aristotle University of Thessaloniki, Greece

Conference

ERS 2020

29 October, 2020 20:08

COVID-19: What is the risk of reinfection?

Presented By

Prof. Peter Openshaw, Imperial College of London, UK

Trial

ISARIC-4C

Conference

ERS 2020

29 October, 2020 20:01

COVID-19 App: The Dutch experience

Presented By

Prof. Niels Chavannes, Leiden University, the Netherlands

Conference

ERS 2020

29 October, 2020 19:57

Secondary pulmonary fibrosis: a possible long-term effect of severe COVID-19

Presented By

Prof. Francesco Blasi , University of Milan, Italy

Conference

ERS 2020

29 October, 2020 16:48

COVID-19 survivors benefit from structured follow-up

Presented By

Dr Sabina Sahanic, Medical University of Innsbruck, Austria

Conference

ERS 2020

29 October, 2020 16:35

Early pulmonary rehabilitation post-COVID-19 aids recovery

Presented By

Ms Yara Al Chikhanie, Grenoble Alps University, France

Conference

ERS 2020

29 October, 2020 15:29

Telemedicine could help rural patients with dementia

Journal

Maturitas

16 October, 2020 22:11

COVID-19-associated delays in aortic-valve replacement tied to worse outcomes

Journal

JAMA Network Open

6 October, 2020 19:35

IBD meds could treat COVID-19

Journal

Gastroenterology

2 October, 2020 18:58

Treatment times of acute STEMI have increased with COVID-19 pandemic

Journal

American Journal of Emergency Medicine

23 September, 2020 18:13

Severe COVID-19 less common in patients with GI symptoms

22 September, 2020 19:10

COVID-19 has disrupted cancer care, particularly among minority groups

Conference

ESMO 2020

22 September, 2020 18:28

COVID-19 can mimic acute stoneless gallbladder attack

Journal

Journal of Hepatology

18 September, 2020 23:24

Smoking linked with increased expression of ACE2 gene in lungs

Journal

medRxiv

11 September, 2020 23:18

Longer-term COVID-19 lung damage can improve over time

Conference

ERS 2020

11 September, 2020 23:06

Pandemic drives adaptations to management guidelines for acute colitis in kids

Journal

Gut

11 September, 2020 19:20

Crosstalk between inflammation and coagulation in severe COVID-19 infections

Presented By

Prof. Roberta Gualtierotti, University of Milan, Italy

Conference

ISTH 2020

8 September, 2020 15:21

COVID-19 associated with higher VTE rates relative to influenza

Presented By

Dr Milou Stals, Leiden University Medical Centre, the Netherlands

Conference

ISTH 2020

8 September, 2020 15:18

Therapeutic anticoagulation not associated with lower mortality rates in COVID-19 ICU patients

Presented By

Dr Hanny Al-Samkari, Massachusetts General Hospital, USA

Trial

Cohort study

Conference

ISTH 2020

8 September, 2020 15:15

COVID-19 not associated with heightened VTE risk after discharge

Presented By

Dr Matthias Engelen, University Hospital Leuven, Belgium

Conference

ISTH 2020

8 September, 2020 15:09

Tau species in spinal fluid may track with brain tau, indicate stage of dementia

Journal

Brain

21 December, 2020 16:14

High risk of vascular dementia in patients with T2D

Presented By

Dr Carlos Celis-Morales, University of Glasgow, Scotland

Conference

EASD 2020

14 December, 2020 12:36

Study supports link between endosomal-traffic defect and Alzheimer’s

Journal

Science Translational Medicine

4 December, 2020 19:52

Neuroinflammation common in familial frontotemporal dementia

Journal

Journal of Neurology, Neurosurgery and Psychiatry

26 November, 2020 20:00

Retinal imaging may predict Alzheimer’s in those at genetic risk

Journal

JAMA Ophthalmology

20 November, 2020 17:11

Plasma P-tau217 emerging as biomarker of early AD

Journal

JAMA Neurology

11 November, 2020 18:18

Predicting MCI and dementia by assessing worrying about memory

Presented By

Prof. Frank Jessen, University Hospital of Cologne, Germany

Trial

Cohort study, AgeCoDe

Conference

ECNP 2020

2 November, 2020 16:49

Genomics of vascular dementia and stroke

Presented By

Prof. Elisabeth Tournier-Lasserve, Saint Louis Hospital, France

Conference

ECNP 2020

2 November, 2020 16:45

The PRISM project: focusing on biological parameters across neuropsychiatric disorders

Presented By

Dr Hugh Marston, Eli Lilly and Company Ltd, Germany

Conference

ECNP 2020

2 November, 2020 15:56

APOE-region variants linked to Alzheimer’s disease risk

Journal

JAMA Network Open

30 October, 2020 22:18

Unique Alzheimer’s disease risk loci found in African Americans

Journal

JAMA Neurology

23 October, 2020 20:20

Novel neuroimaging data have implications for recruitment for Alzheimer’s clinical trials

Journal

JAMA Neurology

21 October, 2020 16:48

Telemedicine could help rural patients with dementia

Journal

Maturitas

16 October, 2020 22:11

Sleep EEG-based brain-age index correlates with dementia

Journal

JAMA Network Open

8 October, 2020 18:23

French ‘Alzheimer’s village’: where nursing home meets the outside world

1 October, 2020 16:11

Non-Alzheimer’s disease pathophysiology in the elderly

Expert

Prof. Philip Scheltens, Amsterdam UMC, the Netherlands

Conference

EAN 2020

8 September, 2020 10:58

Novel genetic association with resistance to ERC tau deposition

Expert

Vijay K Ramanan, Mayo Clinic–Rochester, Minnesota, USA

Conference

EAN 2020

8 September, 2020 10:55

News on AD biomarkers

Conference

EAN 2020

8 September, 2020 10:50

Diastolic dysfunction novel risk factor for cognitive impairment

Expert

Dr A. Parker, Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, USA

Conference

EAN 2020

8 September, 2020 10:08

Diastolic dysfunction novel risk factor for cognitive impairment

17 July, 2020 09:57

News on AD biomarkers

17 July, 2020 09:55

Novel genetic association with resistance to ERC tau deposition

17 July, 2020 09:05

Non-Alzheimer’s disease pathophysiology in the elderly

17 July, 2020 09:02

Diastolic dysfunction novel risk factor for cognitive impairment

27 May, 2020 08:12

Novel genetic association with resistance to ERC tau deposition

20 May, 2020 09:26

Biomarkers and how to use them

Conference

EAN 2019

27 August, 2019 22:54

Antipsychotics increase mortality regardless of comorbidity

Presented By

Dr Ane Nørgaard, Rigshospitalet, Denmark

Conference

EAN 2019

27 August, 2019 21:55

PDD and DLB represent two different disorders

Conference

EAN 2019

27 August, 2019 14:57

Clinical utility of amyloid PET in cognitively impaired patients

9 May, 2019 09:45

Moderate-to-severe CKD tied to worse VTE outcomes

Journal

JAMA Network Open

9 November, 2020 23:36

Similar outcomes sPESI and HESTIA for pulmonary embolism triage

Presented By

Prof. Pierre-Marie Roy, University Hospital of Angers, France

Trial

HOME-PE trial

Conference

ESC 2020

5 November, 2020 13:16

Risk factors for thromboembolism and bleeding in COVID-19: lessons from Wuhan

Presented By

Prof. Yutao Guo , Chinese PLA General Hospital, China

Conference

ESC 2020

5 November, 2020 12:27

DVT screening, early treatment, prevent PE in necrotizing pancreatitis

Journal

Journal of the American College of Surgeons

21 October, 2020 22:19

Physical rehabilitation improves health outcomes after pulmonary embolism

Presented By

Dr Stephan Nopp, Medical University Vienna, Austria

Conference

ISTH 2020

8 September, 2020 16:18

Residual pulmonary obstruction may predict risk of VTE recurrence

Presented By

Dr Robin Chaux, University Hospital St. Etienne, France

Conference

ISTH 2020

8 September, 2020 15:50

Risk of checkpoint inhibitor-associated thromboembolic events important for cancer prognosis

Presented By

Dr Florian Moik, Medical university of Vienna, Austria

Trial

Cohort study

Conference

ISTH 2020

8 September, 2020 15:44

COVID-19 associated with higher VTE rates relative to influenza

Presented By

Dr Milou Stals, Leiden University Medical Centre, the Netherlands

Conference

ISTH 2020

8 September, 2020 15:18

Therapeutic anticoagulation not associated with lower mortality rates in COVID-19 ICU patients

Presented By

Dr Hanny Al-Samkari, Massachusetts General Hospital, USA

Trial

Cohort study

Conference

ISTH 2020

8 September, 2020 15:15

COVID-19 not associated with heightened VTE risk after discharge

Presented By

Dr Matthias Engelen, University Hospital Leuven, Belgium

Conference

ISTH 2020

8 September, 2020 15:09

Higher thrombotic risk in NSCLC patient with ALK rearrangement

Presented By

Dr Hanny Al-Samkari, Massachusetts General Hospital, USA

Conference

ISTH 2020

8 September, 2020 14:41

Apixaban offers new perspective for cancer patients in need of anticoagulation

Presented By

Prof. G. Agnelli, University of Perugia, Italy

Trial

Phase 3, CARAVAGGIO

Conference

ACC 2020

7 September, 2020 23:13

Radiotherapy for rectal cancer linked to risk for later malignant gynecological neoplasms

Journal

JAMA Network Open

8 January, 2021 23:19

Organ preservation possible in early-stage rectal cancer

Journal

Lancet Gastroenterology and Hepatology

1 January, 2021 18:03

Radiotherapy then chemotherapy before surgery may be best in rectal cancer

Journal

The Lancet Oncology

21 December, 2020 17:10

Carcinoid tumors increasing in young adults at a faster clip than adencarcinomas

Journal

Annals of Internal Medicine

14 December, 2020 23:08

Uncovered self-expandable stent likely preferable for malignant gastric outlet obstruction

Journal

Gut

7 December, 2020 15:07

Transanal minimally invasive surgery an option for certain rectal cancer patients

Journal

JAMA Surgery

27 November, 2020 23:52

Rechallenge of RAS/BRAF wildtype CRC with avelumab plus cetuximab

Conference

ESMO 2020

25 November, 2020 15:13

Surveillance after curative treatment for CRC

Conference

ESMO 2020

25 November, 2020 15:11

Adjuvant chemotherapy less effective in elderly CRC patients

Conference

ESMO 2020

25 November, 2020 15:10

Nivolumab plus chemotherapy: new standard for first-line treatment of gastric cancer?

Conference

ESMO 2020

25 November, 2020 15:08

CRC disseminates using collective migration

Conference

ESMO 2020

25 November, 2020 12:30

No survival differences with open or laparoscopic surgery for liver metastases

Journal

Annals of Internal Medicine

16 November, 2020 23:10

Risk-adapted starting ages proposed for colorectal cancer screening in diabetics

Journal

PLoS Medicine

13 November, 2020 20:00

Pembrolizumab prolongs overall survival in some with advanced esophageal cancer

Journal

Journal of Clinical Oncology

13 November, 2020 17:25

Surgeon technical skill has big impact on colon-cancer outcomes

Journal

JAMA Oncology

6 November, 2020 20:29

Adenoma detection rate improves over time

Presented By

Prof. Kumanan Nalankill, Monash University, Australia

Conference

UEGW 2020

2 November, 2020 11:22

Post-colonoscopy colorectal cancers in IBD patients

Presented By

Ms Frederikke S. Troelsen, Aarhus University Hospital, Denmark

Conference

UEGW 2020

2 November, 2020 11:19

Combination checkpoint and VEGF inhibitors now first-line treatment for advanced liver cancer

Journal

JAMA Oncology

28 October, 2020 21:24

Begin colorectal-cancer screening at 45 years, not 50, says USPSTF

27 October, 2020 18:25

Colorectal cancer more likely after first acute diverticulitis

Journal

Diseases of the Colon and Rectum

21 October, 2020 16:45

Linked color imaging bests conventional imaging for upper GI cancer detection

Journal

Annals of Internal Medicine

19 October, 2020 22:22

Invasive features, positive margins tied to worse outcome of precancerous pancreas lesions

Journal

Annals of Surgery

16 October, 2020 20:58

Icotinib plus radiotherapy ups survival in elderly with esophageal cancer

Journal

JAMA Network Open

15 October, 2020 17:49

Surufatinib improves progression-free survival in advanced pancreatic neuroendocrine tumors

Journal

Lancet Oncology

9 October, 2020 21:52

MR-Linac-delivered adaptive radiation therapy promising in pancreatic cancer

Journal

Practical Radiation Oncology

9 October, 2020 15:08

Vascular invasion, tumor deposits more prognostic than TNM for rectal cancer

Journal

Annals of Surgery

30 September, 2020 22:59

Liquid biopsy might help detect, manage liver cancer in the future

Journal

Gut

21 September, 2020 17:43

HER2-expressing metastatic colorectal cancer: trastuzumab deruxtecan

Expert

Prof. Salvatore Siena, University of Milan Niguarda Cancer Center, Italy

Trial

Phase 3, DESTINY-CRC01

Conference

ASCO 2020

17 September, 2020 15:00

Pembrolizumab as first-line in MSI-H mCRC

Expert

Prof. Thierry André, St Antoine Hospital, France

Trial

Phase 3, KEYNOTE-177

Conference

ASCO 2020

17 September, 2020 14:55

REGOMUNE: a phase 2 study combining regorafenib and avelumab

Expert

Dr Sophie Cousin, Institut Bergonié, France

Trial

Phase 1/2, REGOMUNE

Conference

ASCO 2020

17 September, 2020 14:52

Cardiotoxicity: consider switching to S-1

Expert

Prof. Pia Österlund, Tampere University Hospital, Finland

Conference

ASCO 2020

17 September, 2020 14:49

Perioperative chemotherapy for resectable pancreatic ductal adenocarcinoma

Expert

Prof. Davendra Sohal, University of Cincinnati, OH, USA

Trial

Phase 2, SWOG S1505

Conference

ASCO 2020

17 September, 2020 14:47

Real-world data of sequential sorafenib followed by regorafenib in unresectable HCC

Expert

Dr Philippe Merle, Groupement Hospitalier Lyon Nord, France

Trial

REFINE

Conference

ASCO 2020

17 September, 2020 14:45

Eflornithine-sulindac combo may not offer extra benefit for familial adenomatous polyposis

Journal

New England Journal of Medicine

9 September, 2020 23:00

Real-world data of sequential sorafenib followed by regorafenib in unresectable HCC

3 August, 2020 11:43

Perioperative chemotherapy for resectable pancreatic ductal adenocarcinoma

3 August, 2020 11:41

Cardiotoxicity: consider switching to S-1

3 August, 2020 11:39

REGOMUNE: a phase 2 study combining regorafenib and avelumab

3 August, 2020 11:37

Pembrolizumab as first-line in MSI-H mCRC

3 August, 2020 11:35

HER2-expressing metastatic colorectal cancer: trastuzumab deruxtecan

3 August, 2020 11:33

HER2-expressing metastatic colorectal cancer: trastuzumab deruxtecan

3 June, 2020 08:38

Cardiotoxicity: consider switching to S-1

29 May, 2020 12:28

Pembrolizumab as first-line in MSI-H mCRC

29 May, 2020 12:24

Role of immune cells in intestinal fibrosis

Presented By

Dr B. Creyns, Catholic University Leuven, Leuven, Belgium

Conference

ECCO 2020

14 April, 2020 16:04

Increased risk of small bowel cancer in IBD

Presented By

Dr J. Axelrad, New York University School of Medicine, New York, USA

Conference

ECCO 2020

14 April, 2020 15:53

Increased incidence of colorectal cancer and death in CD

Presented By

Dr O. Olen, Karolinska Insitutet, Solna, Sweden

Trial

Cohort study

Conference

ECCO 2020

14 April, 2020 15:51

Risk of rectal, anal cancer increased in perianal CD

Presented By

Dr M.D. Wewer, University of Copenhagen, Copenhagen, Denmark

Conference

ECCO 2020

14 April, 2020 15:48

Glyco-fingerprint as risk factor of UC-associated cancer

Presented By

Dr A. Dias, Newham University Hospital, London, United Kingdom

Conference

ECCO 2020

14 April, 2020 15:44

Liquid biopsies helpful in prostate cancer, but most not ready for routine use

Journal

European Urology

29 January, 2021 23:58

Post-prostatectomy urinary outcomes vary widely by patient and surgeon

Journal

JAMA Surgery

27 January, 2021 23:27

Aspirin tied to improved breast, bladder cancer survival in older adults

Journal

JAMA Network Open

26 January, 2021 21:33

ADT add-ons helpful in metastatic prostate cancer

Journal

JAMA Oncology

20 January, 2021 16:01

Statin use tied to better outcomes in men with prostate cancer starting androgen-deprivation therapy

Journal

European Urology

7 January, 2021 19:00

Pembrolizumab plus bevacizumab and oral cyclophosphamide beneficial in recurrent ovarian cancer

Journal

JAMA Oncology

2 December, 2020 22:45

Abiraterone in M1 hormone-naïve prostate cancer

Conference

ESMO 2020

25 November, 2020 14:51

New treatment option for patients with mCRPC

Conference

ESMO 2020

25 November, 2020 14:50

First-line treatment of advanced/metastatic RCC

Conference

ESMO 2020

25 November, 2020 14:44

First-line immune-combination therapies in mUC

Trial

Phase 3, KEYNOTE-361

Conference

ESMO 2020

25 November, 2020 14:43

Second- and third-line treatment options in mUC

Conference

ESMO 2020

25 November, 2020 14:41

Palbociclib effective in ER-positive endometrial cancer

Conference

ESMO 2020

25 November, 2020 14:23

Liquid-biopsy testing in prostate cancer may lead to inappropriate treatment

Journal

JAMA Oncology

11 November, 2020 18:01

Platinum-based therapy could be helpful in some with advanced prostate cancer

Journal

JAMA Network Open

5 November, 2020 18:03

Active surveillance appears to be safe option for Black men with low-risk prostate cancer

Journal

JAMA

3 November, 2020 18:53

New prostate-cancer staging system may improve pretreatment prognostication

Journal

JAMA Oncology

30 October, 2020 19:18

Image-guided intensity-modulated radiation cuts late GI toxicity after cervical cancer

Conference

ASTRO 2020

30 October, 2020 19:15

Men with localized prostate cancer have reduced long-term quality of life

Journal

BMJ

29 October, 2020 19:26

Women with cervical cancer at increased risk of injury during diagnostic workup

Journal

Cancer Epidemiology, Biomarkers & Prevention

21 October, 2020 22:18

Rates of bone density testing in men initiating ADT low but rising

Journal

Journal of the National Comprehensive Cancer Network

21 October, 2020 16:08

Upfront chemo does not appear to worsen ovarian-cancer survival

Journal

JAMA Network Open

12 October, 2020 20:17

Radiation therapy, brachytherapy outcomes similar for localized prostate cancer

Journal

JAMA Network Open

7 October, 2020 22:40

Quality of life appears to suffer little when adding radiation to androgen deprivation for prostate cancer

Journal

European Urology

6 October, 2020 18:44

Delaying radiation likely preferable after localized prostate cancer resection

Journal

The Lancet

5 October, 2020 23:11

HPV vaccination tied to lower risk of invasive cervical cancer

Journal

New England Journal of Medicine

30 September, 2020 23:00

New drug shows promise in metastatic prostate cancer

Conference

ESMO 2020

25 September, 2020 20:30

Proton-pump inhibitors may reduce benefits of atezolizumab in urothelial carcinoma

Journal

Clinical Cancer Research

23 September, 2020 18:12

Avelumab shows survival benefit against advanced urothelial cancer

Journal

New England Journal of Medicine

Conference

ESMO 2020

21 September, 2020 23:27

Urothelial cancer: avelumab works as maintenance therapy

Expert

Prof. Thomas Powles, Barts Cancer Institute, UK

Trial

Phase 3, JAVELIN Bladder 100

Conference

ASCO 2020

17 September, 2020 14:30

ARAMIS final OS and nmCRPC safety outcomes

Expert

Prof. Karim Fizazi, Institut Gustave Roussy, France

Trial

Phase 3, ARAMIS

Conference

ASCO 2020

17 September, 2020 14:11

Final survival results from phase 3 SPARTAN trial

Expert

Prof. Eric J. Small, University of California San Francisco, CA, USA

Trial

Phase 3, SPARTAN

Conference

ASCO 2020

17 September, 2020 14:01

Novel drug for kidney cancers/VHL patients

Expert

Prof. Eric Jonasch, University of Texas MD Anderson Cancer Center, USA

Trial

Phase 2

Conference

ASCO 2020

17 September, 2020 13:59

Primary analysis from IMvigor010, adjuvant atezolizumab in high risk muscle-invasive urothelial carcinoma

Expert

Dr Maya H.A. Hussain, Northwestern University in Chicago, IL, USA

Trial

Phase 3, IMvigor010

Conference

ASCO 2020

17 September, 2020 13:57

First randomised trial of Lu-PSMA in mCRPC progressing after docetaxel

Expert

Prof. Michael S. Hofman, Peter MacCallum Cancer Centre, Australia

Trial

TheraP

Conference

ASCO 2020

17 September, 2020 13:54

Follow-up confirms apalutamide survival benefits in some men with prostate cancer

Journal

European Urology

16 September, 2020 20:56

Androgen deprivation appears beneficial in unfavorable intermediate-risk PC

Journal

JAMA Network Open

11 September, 2020 19:23

Accurate prediction of bladder-cancer response to neoadjuvant chemotherapy remains elusive

Journal

European Urology

10 September, 2020 16:04

Darolutamide lowers risk of death by 31% for some prostate-cancer patients

Journal

New England Journal of Medicine

9 September, 2020 23:00

Ipilimumab prolongs overall survival in metastatic castration-resistant prostate cancer

Journal

European Urology

8 September, 2020 15:40

Maintenance olaparib improves OS in relapsed ovarian cancer with BRCA1/2 mutation

Presented By

Prof. Andrés Poveda, Hospital Quironsalud, Spain

Trial

Phase 3, SOLO2/ENGOT-ov21

Conference

ASCO 2020

8 September, 2020 09:35

DNA-methylation test shows promise in bladder-cancer detection, monitoring

Journal

Journal of Clinical Investigation

7 September, 2020 17:57

Infertility and testis cancer risk: causal or association?

Presented By

Prof. Leendert Looijenga , Princess Máxima Center for Pediatric Oncology, the Netherlands

Conference

EAU 2020

24 August, 2020 14:15

Prostatectomy: R-LRPE better than LRPE for continence

Principal Investigator

Prof. Jens-Uwe Stolzenburg , University of Leipzig, Germany

Trial

LAP-01

Conference

EAU 2020

21 August, 2020 14:49

PSMA PET-CT staging is 27% more accurate

Principal Investigator

Prof. Michael Hofman, Peter MacCallum Cancer Centre, Australia

Trial

ProPSMA

Conference

EAU 2020

21 August, 2020 14:40

Docetaxel + hormonal therapy: improved prostate cancer PFS

Presented By

Dr Andreas Josefsson , Sahlgrenska University Hospital, Sweden

Trial

Phase 3, SPCG-14

Conference

EAU 2020

21 August, 2020 14:34

ARAMIS subgroup analysis: darolutamide benefits across PSADT groups

Principal Investigator

Prof. Martin Bögemann, University of Münster, Germany

Trial

Phase 3, ARAMIS

Conference

EAU 2020

21 August, 2020 13:42

Infertility and testis cancer risk: causal or association?

21 August, 2020 11:16

Peyronie’s disease: surgical options

21 August, 2020 11:10

Targeting steroid sulphatase in resistant prostate cancer cells

21 August, 2020 10:19

Large patient-driven survey reveals QoL issues after prostate cancer treatment

21 August, 2020 10:17

ARAMIS subgroup analysis: darolutamide benefits across PSADT groups

21 August, 2020 10:15

Docetaxel + hormonal therapy: improved prostate cancer PFS

21 August, 2020 10:12

PSMA PET-CT staging is 27% more accurate

21 August, 2020 10:09

Prostatectomy: R-LRPE better than LRPE for continence

21 August, 2020 10:07

Understanding MIBC biology for novel treatment options

21 August, 2020 09:22

Nadofaragene firadenovec effective in BCG-unresponsive papillary NMIBC

21 August, 2020 09:17

Large patient-driven survey reveals QoL issues after prostate cancer treatment

Presented By

Mr André Deschamps , Europa Uomo, Belgium

Trial

EUPROMS

Conference

EAU 2020

20 August, 2020 13:05

Targeting steroid sulphatase in resistant prostate cancer cells

Presented By

Prof. Allen C. Gao , University of California Davis, USA

Conference

EAU 2020

20 August, 2020 13:00

Good tolerance of post-RP radiotherapy ± short-term ADT

Presented By

Dr Paul Sargos , Institut Bergonié, France

Trial

Phase 2, GETUG-AFU 22

Conference

EAU 2020

20 August, 2020 12:54

Reduced BCG frequency, faster NMIBC recurrence

Presented By

Prof. Marc-Oliver Grimm, University Hospital Jena, Germany

Trial

Phase 3, NIMBUS

Conference

EAU 2020

20 August, 2020 12:51

Nadofaragene firadenovec effective in BCG-unresponsive papillary NMIBC

Presented By

Dr Neal Shore, Carolina Urologic Research Center, USA

Conference

EAU 2020

20 August, 2020 12:44

Understanding MIBC biology for novel treatment options

Presented By

Prof. Yohann Loriot, Université Paris-Saclay, France

Trial

BLC2001; THOR; EV-301; EV-302; TROPHY-U-01; RANGE

Conference

EAU 2020

20 August, 2020 12:36

First randomised trial of Lu-PSMA in mCRPC progressing after docetaxel

3 August, 2020 11:30

Primary analysis from IMvigor010, adjuvant atezolizumab in high risk muscle-invasive urothelial carcinoma

3 August, 2020 11:28

Novel drug for kidney cancers/VHL patients

3 August, 2020 11:27

Final survival results from phase 3 SPARTAN trial

3 August, 2020 10:34

ARAMIS final OS and nmCRPC safety outcomes

3 August, 2020 10:32

Urothelial cancer: avelumab works as maintenance therapy

3 August, 2020 10:29

Maintenance olaparib improves OS in relapsed ovarian cancer with BRCA1/2 mutation

31 July, 2020 10:47

Docetaxel + hormonal therapy: improved prostate cancer PFS

21 July, 2020 11:00

Infertility and testis cancer risk: causal or association?

21 July, 2020 10:57

PSMA PET-CT staging is 27% more accurate

21 July, 2020 10:55

Understanding MIBC biology for novel treatment options

20 July, 2020 08:39

Reduced BCG frequency = faster NMIBC recurrence

20 July, 2020 08:34

Prostatectomy: R-LRPE better than LRPE for continence

20 July, 2020 08:32

Novel drug for kidney cancers/VHL patients

3 June, 2020 08:42

Maintenance olaparib improves OS in relapsed ovarian cancer with BRCA1/2 mutation

2 June, 2020 07:50

Urothelial cancer: avelumab works as maintenance therapy

29 May, 2020 12:11

Mindfulness-based stress reduction tied to less disability, depression with migraine

Journal

JAMA Internal Medicine

14 December, 2020 23:11

Later school start time linked to fewer migraines in adolescents

Journal

Headache: The Journal of Head and Face Pain

7 December, 2020 20:11

Prednisone can help prevent episodic cluster headache

Journal

The Lancet Neurology

3 December, 2020 18:05

Improvement of migraine using CGRP mAbs in a real-world setting

Presented By

Prof. Robert E. Shapiro, University of Vermont, VT, USA

Trial

OVERCOME

Conference

MTIS 2020

27 October, 2020 15:47

Similar treatment needs for high-frequency episodic and low-frequency chronic migraine

Presented By

Prof. Richard B. Lipton, Albert Einstein College of Medicine, NY, USA

Trial

CaMEO

Conference

MTIS 2020

27 October, 2020 15:44

Nitroglycerin-induced cluster headache attacks characterised comprehensively

Presented By

Dr Diana Y. Wei, King's College London, UK

Conference

MTIS 2020

27 October, 2020 15:40

Remote electrical neuromodulation useful for adolescents with migraine

Presented By

Dr Andrew D. Hershey, Cincinnati Children's Hospital Medical Center, USA

Conference

MTIS 2020

27 October, 2020 15:38

Concomitant preventive medication has no impact on efficacy of ubrogepant

Presented By

Dr Andrew M. Blumenfeld, Headache Center of Southern California, USA

Trial

Phase 3, ACHIEVE I and II

Conference

MTIS 2020

27 October, 2020 15:36

No new cardiovascular safety concerns with long-term use of lasmiditan

Presented By

Dr H. Hochstetler

Trial

Phase 3, GLADIATOR

Conference

MTIS 2020

27 October, 2020 15:19

Less medication use and fewer doctor visits with galcanezumab in treatment-resistant migraine

Presented By

Prof. Julio P. Gómez, Hospital Universitario Marqués de Valdecilla, Spain

Trial

Phase 3, CONQUER

Conference

MTIS 2020

27 October, 2020 15:16

Real-world evidence reveals physicians’ perception of erenumab

Presented By

Dr Mirja Koch, Clinical Research Neuroscience, Novartis Pharma GmbH, Germany

Trial

TELESCOPE

Conference

MTIS 2020

27 October, 2020 15:14

Early initiation of lasmiditan improves migraine outcomes

Presented By

Dr Mario F. Peres, Hospital Israelita Albert Einstein, Brazil

Trial

Phase 3, GLADIATOR

Conference

MTIS 2020

27 October, 2020 15:11

Fremanezumab effective in patients with migraine and comorbid depression

Presented By

Prof. Dawn C. Buse, Albert Einstein College of Medicine, NY, USA

Trial

Phase 3, FOCUS, HALO

Conference

MTIS 2020

27 October, 2020 15:08

Long-term onabotulinumtoxinA improves quality of life in migraine

Presented By

Dr Guy Boudreau, Centre Hospitalier Universitaire de Montréal, Canada

Trial

PREDICT

Conference

MTIS 2020

27 October, 2020 15:04

Sustained shift in migraine status using galcanezumab

Presented By

Dr William S. Kingston, Sunnybrook Health Sciences Centre, Canada

Trial

Phase 3, CONQUER

Conference

MTIS 2020

27 October, 2020 14:35

Worldwide survey shows substantial burden of migraine

Presented By

Dr D.D. Mitsikostas

Conference

MTIS 2020

27 October, 2020 14:33

Long-term efficacy and safety of fremanezumab in treatment-resistant migraine

Presented By

Dr M. Ashina

Trial

Phase 3, FOCUS

Conference

MTIS 2020

27 October, 2020 14:31

Injection-site reactions with galcanezumab are mild and self-limiting

Presented By

Dr V.L. Stauffer

Trial

Phase 3, CONQUER

Conference

MTIS 2020

27 October, 2020 14:27

Beta-blocker eye drops may alleviate migraine pain

Journal

JAMA Ophthalmology

2 October, 2020 00:25

Migraine as a cyclical functional disorder

Presented By

Mr Daniele Martinelli, University of Pavia, Italy

Conference

EAN 2020

10 September, 2020 11:07

Reassuring real-world safety profile of 3 CGRP inhibitors

Presented By

Prof. Stephen D. Silberstein, Thomas Jefferson University, PA, USA

Conference

EAN 2020

10 September, 2020 11:03

Long-term cardiovascular safety of erenumab

Presented By

Dr Stewart Tepper, Geisel School of Medicine, USA

Conference

EAN 2020

10 September, 2020 10:58

Real-world data for erenumab in Germany

Presented By

Prof. Andreas Straube, Ludwig-Maximilians-University Munich, Germany

Trial

TELESCOPE

Conference

EAN 2020

9 September, 2020 17:13

Eptinezumab in chronic migraine and medication-overuse headache

Presented By

Prof. Hans-Christoph Diener, Medical Faculty of the University Duisburg-Essen, Germany

Trial

Phase 3, PROMISE-2

Conference

EAN 2020

9 September, 2020 17:09

Fremanezumab tolerability in cardiovascular patients with migraine

Presented By

Dr Gianluca Coppola, Sapienza University of Rome, Italy

Trial

Phase 3, HALO, FOCUS

Conference

EAN 2020

9 September, 2020 17:05

Effects of galcanezumab on health-related quality of life

Presented By

Dr Stewart Tepper, Geisel School of Medicine, USA

Trial

Phase 3, CONQUER

Conference

EAN 2020

9 September, 2020 16:44

Unmet needs and pipeline

Presented By

Prof. Christian Lampl, Headache Medical Center, Austria

Conference

EAN 2020

9 September, 2020 16:39

Could statins protect the heart from breast-cancer chemotherapy?

Journal

Journal of the American Heart Association

6 January, 2021 16:36

TTR V122I variant linked to adverse cardiac mechanics in middle-aged Black Americans

Journal

JAMA Cardiology

4 January, 2021 22:31

Study links fracking operations to worsening heart failure

Journal

Journal of the American College of Cardiology

7 December, 2020 20:36

Sedentary time tied to heart failure hospitalization in postmenopausal women

Journal

Circulation: Heart Failure

4 December, 2020 17:50

SGLT2 inhibitor reduces filling pressure in HFrEF patients

Journal

Journal of the American College of Cardiology

3 December, 2020 18:03

Women fare worse after first severe heart attack

Journal

Circulation

1 December, 2020 19:35

Pre-recorded discharge instructions improve outcomes for heart-failure patients

Conference

AHA 2020

19 November, 2020 21:51

Risks highest for heart-failure patients soon after index hospitalization

Journal

JAMA Cardiology

19 November, 2020 21:43

Studies show cardiovascular benefit with sotagliflozin

Journal

New England Journal of Medicine

Conference

AHA 2020

17 November, 2020 03:06

Correcting iron deficiency protects heart failure patients from repeat hospital stay

Journal

The Lancet

Conference

AHA 2020

16 November, 2020 20:28

Amgen drug shaves 8% off risk of heart-failure event or heart death

Journal

New England Journal of Medicine

Conference

AHA 2020

13 November, 2020 22:51

Cytokinetics heart failure drug succeeds but slightly higher death rate seen -study

Conference

AHA 2020

13 November, 2020 18:23

SGLT2 inhibitor improves cardiovascular outcomes in heart failure patients

Presented By

Dr Milton Packer, Baylor University Medical Center, USA

Trial

Phase 3, EMPEROR-Reduced trial

Conference

ESC 2020

5 November, 2020 13:40

Reduced NT-proBNP in HFpEF with sacubitril/valsartan

Presented By

Prof. Burkert Pieske, Charité University Medicine Berlin, Germany

Trial

Phase 3, PARALLAX study

Conference

ESC 2020

5 November, 2020 13:26

SGLT2 inhibitor ertugliflozin shows similar mortality but fewer HF hospitalisations

Presented By

Prof. Francesco Cosentino, Karolinska University Hospital, Sweden

Trial

VERTIS CV

Conference

ESC 2020

5 November, 2020 12:39

Myocardial recovery common with LVADs

Journal

Circulation

2 November, 2020 18:21

Metabolic surgery linked to better cardiovascular outcomes after heart attack

Journal

Circulation

28 October, 2020 17:10

Serum omega-3 fatty acids tied to improved STEMI prognosis

Journal

Journal of the American College of Cardiology

26 October, 2020 21:12

Ertugliflozin passes post-approval cardiovascular safety test

Journal

New England Journal of Medicine

23 September, 2020 23:18

Non-physicians may optimize heart failure drugs remotely

Journal

JAMA Cardiology

22 September, 2020 22:27

Mavacamten shows promising results in non-obstructive hypertrophic cardiomyopathy

Presented By

Dr Carolyn Y. Ho, Brigham and Women's Hospital, USA

Trial

Phase 2, MAVERICK-HCM

Conference

ACC 2020

7 September, 2020 17:57

Sacubitril-valsartan in hospitalized HF patients could have benefits

Journal

JAMA Cardiology

7 September, 2020 17:53

Vericiguat shows beneficial effects in a very high-risk HF population

Presented By

Prof. Paul Armstrong, University of Alberta, Canada

Trial

Phase 3, Victoria

Conference

ACC 2020

7 September, 2020 17:48

Heart-failure patients who have received flu and pneumonia shots have better outcomes

Conference

ESC 2020

3 September, 2020 17:48

IBD patients with clinical remission often malnourished, sarcopenic

Journal

European Journal of Gastroenterology and Hepatology

5 February, 2021 22:59

IV ferric carboxymaltose tops IV iron sucrose for iron-deficiency anemia in IBD

Journal

Cochrane Database of Systematic Reviews

1 February, 2021 16:15

Cigarette smoke tied to colorectal neoplasia in IBD patients

Journal

Clinical Gastroenterology & Hepatology

29 January, 2021 18:45

Wearable sweat sensor may help predict IBD flareups

Journal

Crohn's and Colitis Congress

29 January, 2021 16:16

Promising longer-term data for etrasimod in ulcerative colitis

Journal

Journal of Crohn's and Colitis

27 January, 2021 21:11

COVID-19 vaccine recommended for all patients with IBD

Journal

Gut

26 January, 2021 20:52

First-line infliximab beneficial in kids with moderate-to-severe Crohn’s

Journal

Gut

7 January, 2021 18:55

New PROM for Crohn’s perianal fistula has clinical, research potential

Journal

Gut

5 January, 2021 21:45

PPI therapy may render infliximab less effective in IBD patients

Journal

Gut

24 December, 2020 20:41

Anti-cytokine therapy normalizes ACE2 expression in IBD, may protect against COVID-19

Journal

Gastroenterology - AGA

23 November, 2020 22:33

Race, ethnicity affect epidemiology and management of inflammatory bowel diseases

Journal

Gastroenterology

3 November, 2020 19:40

Sustained efficacy of mirikizumab in moderate-to-severe Crohn’s disease

Principal Investigator

Prof. Bruce E. Sands, Icahn School of Medicine at Mount Sinai, NY, USA

Trial

Phase 2, SERENITY

Conference

UEGW 2020

2 November, 2020 12:20

No improvements of remission with etrolizumab in ulcerative colitis

Presented By

Prof. Séverine Vermeire, University of Leuven, Belgium

Trial

Phase 3, LAUREL

Conference

UEGW 2020

2 November, 2020 12:10

Filgotinib effective as maintenance treatment for ulcerative colitis

Presented By

Prof. L Peyrin-Biroulet, Nancy University Hospital, France

Trial

Phase 3, SELECTION

Conference

UEGW 2020

2 November, 2020 12:08

Post-colonoscopy colorectal cancers in IBD patients

Presented By

Ms Frederikke S. Troelsen, Aarhus University Hospital, Denmark

Conference

UEGW 2020

2 November, 2020 11:19

Risk factors for severe COVID-19 among IBD patients

Presented By

Dr Ryan C. Ungaro, Icahn School of Medicine at Mount Sinai, USA

Trial

SECURE-IBD

Conference

UEGW 2020

2 November, 2020 11:13

First randomised T2T trial using endoscopy to guide dose escalation

Principal Investigator

Prof. Silvio Danese, Humanitas University, Italy

Trial

Phase 3, STARDUST

Conference

UEGW 2020

2 November, 2020 11:00

In utero exposure to IBD drugs doesn’t up kids’ infection risk

Journal

Gut

28 October, 2020 17:15

Cobitolimod might induce remission in moderate-to-severe left-sided ulcerative colitis

Journal

Lancet Gastroenterology and Hepatology

26 October, 2020 15:27

Bioenhanced curcumin may induce remission in ulcerative colitis

Journal

Journal of Clinical Gastroenterology

21 October, 2020 16:47

Thiopurine alone maintains remission in more than half of UC patients

Journal

Gut

14 October, 2020 20:51

IBS symptoms common in patients with IBD in remission

Journal

The Lancet Gastroenterology and Hepatology

9 October, 2020 17:54

IBD meds could treat COVID-19

Journal

Gastroenterology

2 October, 2020 18:58

Obesity rising among hospitalized Crohn’s patients

Journal

Journal of Clinical Gastroenterology

25 September, 2020 20:35

Pandemic drives adaptations to management guidelines for acute colitis in kids

Journal

Gut

11 September, 2020 19:20

Asymptomatic SARS-CoV-2 infection common in IBD patients

Journal

Gastroenterology

4 September, 2020 19:44

Resolution of mucosal inflammation has dramatic effect

Presented By

Dr N. Plevris, Western General Hospital, Edinburgh, UK

Trial

Cohort study

Conference

ECCO 2020

14 April, 2020 16:15

Re-inducing inflammation in organoids from UC patients

Presented By

Dr K. Arnauts, Catholic University of Leuven, Belgium

Conference

ECCO 2020

14 April, 2020 16:07

Role of immune cells in intestinal fibrosis

Presented By

Dr B. Creyns, Catholic University Leuven, Leuven, Belgium

Conference

ECCO 2020

14 April, 2020 16:04

Association between meat consumption and IBD risk

Presented By

Dr C. Dong, Peking University, Beijing, China

Trial

EPIC-IBD

Conference

ECCO 2020

14 April, 2020 16:01

Increased risk of small bowel cancer in IBD

Presented By

Dr J. Axelrad, New York University School of Medicine, New York, USA

Conference

ECCO 2020

14 April, 2020 15:53

Effects of vedolizumab versus adalimumab on QoL

Presented By

Dr E.V. Loftus, Mayo Clinic, USA

Trial

VARSITY

Conference

ECCO 2020

14 April, 2020 15:39

On the cutting edge of pathology and surgery

Presented By

Prof. P. B. Nunes & Prof. A. Spinelli

Conference

ECCO 2020

14 April, 2020 15:23

Impact of strategies on intestinal resection rate

Presented By

Dr D. Ley, University of Wisconsin–Madison, USA

Conference

ECCO 2020

14 April, 2020 15:16

Early ileocaecal resection in CD patients failing conventional treatment

Presented By

Dr T. Stevens, Amsterdam UMC, the Netherlands

Trial

LIR!C

Conference

ECCO 2020

14 April, 2020 15:11

Ustekinumab in CD: a T2T trial

Presented By

Prof. L. Peyrin-Biroulet, CHRU de Nancy, France

Trial

Phase 3, STARDUST

Conference

ECCO 2020

14 April, 2020 14:26

Subcutaneous ustekinumab as maintenance therapy in UC

Presented By

Dr R. Panaccione & Dr W.J. Sandborn

Trial

UNIFI

Conference

ECCO 2020

14 April, 2020 14:22

Subcutaneous vedolizumab maintenance therapy in CD

Presented By

Prof. S. Vermeire, University Hospital Leuven, Belgium

Trial

Phase 3, VISIBLE 2

Conference

ECCO 2020

14 April, 2020 14:11

Vedolizumab treatment persistence and safety

Presented By

Dr S. Danese & Dr N.A. Cohen, Humanitas University, Milan, Italy

Trial

GEMINI

Conference

ECCO 2020

14 April, 2020 14:04

Pipeline of IBD drugs

Presented By

Prof. W. Sandborn, University of California San Diego, USA

Conference

ECCO 2020

14 April, 2020 13:55

Phase 2 results of first-in-class TL1A inhibitor

Presented By

Dr S. Danese, Humanitas University, Italy

Trial

Phase 2, TUSCANY

Conference

ECCO 2020

14 April, 2020 12:58

Open-label extension study of risankizumab: final results

Presented By

Dr M. Ferrante, University Hospitals Leuven, Belgium

Conference

ECCO 2020

14 April, 2020 12:53

Clinical remission after dose escalation of upadacitinib

Presented By

Dr W. Sandborn & Dr S. Vermeire

Trial

Phase 2, CELEST, U-ACHIEVE

Conference

ECCO 2020

14 April, 2020 12:45

Possible new treatment targets in IBD

Conference

ECCO 2020

14 April, 2020 12:39

Response to faecal microbiota transplantation in UC

Presented By

Dr M. Quraishi, University Hospital Birmingham, UK; Dr L. Gogokhia, Weill Cornell Medicine, New York, USA

Trial

STOP-Colitis

Conference

ECCO 2020

14 April, 2020 10:55

Multi-omics help describe CD phenotypes

Presented By

Dr B. Verstockt, University Hospital Leuven, Belgium

Conference

ECCO 2020

14 April, 2020 10:46

The positive impact of genetic data on drug development

Presented By

Prof. S. Vermeire, University Hospital Leuven, Belgium

Conference

ECCO 2020

14 April, 2020 10:45

Bioactives produced by gut bacteria to modulate immune response

Presented By

R. Giri, University of Queensland, Australia

Conference

ECCO 2020

14 April, 2020 10:13

ECCO 2020 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

ECCO 2020

25 March, 2020 11:54

Bosutinib effective and well tolerated in newly diagnosed CP-CML

Presented By

Prof. Tim Brümmendorf, RWTH Aachen University, Germany

Trial

Phase 3, BFORE

Conference

ASH 2020

18 February, 2021 11:17

Efficacy and safety of ponatinib in patients with CP-CML who failed second-generation TKIs

Presented By

Dr Hagop Kantarjian, MD Anderson Cancer Center, Texas, USA

Trial

OPTIC, PACE

Conference

ASH 2020

18 February, 2021 11:08

First-in-class STAMP inhibitor versus bosutinib in resistant or intolerant CML

Presented By

Dr Andreas Hochhaus, Universitätsklinikum Jena, Germany

Trial

Phase 3, ASCEMBL

Conference

ASH 2020

18 February, 2021 10:58

PFS and ORR benefits of first-line ibrutinib-based treatment in CLL

Presented By

Prof. Jan Burger, MD Anderson Cancer Center, Texas, USA

Trial

Phase 3, RESONATE-2, iLLUMINATE

Conference

ASH 2020

18 February, 2021 10:54

PARP inhibitors linked to myelodysplastic syndrome, AML, meta-analysis confirms

Journal

The Lancet Haematology

12 January, 2021 16:14

Origins of blood cancer traced to early childhood, decades before diagnosis

Conference

American Society of Hematology 2020 Annual Meeting

17 December, 2020 17:42

First-in-class STAMP inhibitor superior to bosutinib in chronic phase CML

Presented By

Dr Andreas Hochhaus , Klinik für Innere Medizin II, Germany

Trial

Phase 3, ASCEMBL

Conference

ASH 2020

9 December, 2020 14:26

Transcriptional and genomic analyses powerful for better understanding ALL subtypes

Presented By

Dr Lindsey Montefiori , St. Jude Children's Research Hospital, Tennessee, USA

Conference

ASH 2020

9 December, 2020 14:21

New mechanism in atypical CML detected and tackled

Presented By

Dr Diletta Fontana, University of Milano-Bicocca, Italy

Conference

ASH 2020

9 December, 2020 14:20

Peripheral blood monitoring offers a viable alternative to monitor treatment response in acute lymphoblastic leukaemia

Presented By

Dr Lori Muffly, Stanford University, California, USA

Conference

ASH 2020

8 December, 2020 11:16

Bosutinib demonstrates efficacy superior to imatinib

Presented By

Dr Tim Brümmendorf, Center for Integrated Oncology, Germany

Conference

ASH 2020

8 December, 2020 11:15

Ponatinib provides a therapeutic option for leukaemia patients who have failed previous TKI therapy

Presented By

Dr Hagop Kantarjian, University of Texas MD Anderson Cancer Center, Texas, USA

Conference

ASH 2020

8 December, 2020 11:12

Cytoreductive chemotherapy in acute myeloid leukaemia deemed safe

Presented By

Dr Kim Kunhwa, University of Texas MD Anderson Cancer Center, Texas, USA

Conference

ASH 2020

8 December, 2020 11:10

Acute Myeloid Leukaemia-Composite Model successfully predicts both early and late mortality

Presented By

Dr Shannon Murphy, Dalhousie University, Canada

Conference

ASH 2020

8 December, 2020 11:09

Venetoclax-hypomethylating agent combination therapy shows promising results in favourable-risk acute myeloid leukaemia

Presented By

Dr Shukaib Arslan, City of Hope National Medical Center, California, USA

Conference

ASH 2020

8 December, 2020 11:07

New therapy option emerges for chronic myeloid leukaemia patients

Presented By

Dr Alejandro Luna, Hospital Universitario Ramón y Cajal, Spain

Conference

ASH 2020

7 December, 2020 11:22

Tyrosine kinase inhibitor discontinuation can improve CML outcomes

Journal

JAMA Oncology

25 November, 2020 21:36

New guideline helps patients and parents navigate pediatric acute lymphoblastic leukemia

Journal

National Comprehensive Cancer Network

7 October, 2020 21:24

OS benefit in VIALE-C trial

Presented By

Prof. Andrew Wei, Monash University, Australia

Trial

Phase 3, VIALE-C

Conference

EHA 2020

9 September, 2020 13:22

DEC10-VEN superior to intensive chemotherapy in high-risk AML

Presented By

Dr Abhishek Maiti, University of Texas MD Anderson Cancer Centre, USA

Trial

Phase 2

Conference

EHA 2020

9 September, 2020 13:18

Magrolimab plus azacitidine: good ORR in MDS/AML

Presented By

Prof. Naval Draver, University of Texas MD Anderson Cancer Centre, USA

Trial

Phase 1

Conference

EHA 2020

9 September, 2020 13:14

Asciminib monotherapy in Ph+ CML: major molecular responses

Presented By

Prof. Timothy Hughes, University of Adelaide, Australia

Trial

Phase 1

Conference

EHA 2020

9 September, 2020 13:08

CML TKI interruption: Swedish registry results

Presented By

Dr Hjalmar Flygt, Uppsala University Hospital, Sweden

Conference

EHA 2020

9 September, 2020 13:03

Better outcomes adding enasidenib to azacitidine in mIDH2-AML

Presented By

Dr Courtney Di Nardo, MD Anderson Cancer Centre, USA

Trial

Phase 2, AG-221-AML-005

Conference

EHA 2020

9 September, 2020 12:55

Two trials: acalabrutinib in CLL

Presented By

Prof. John Byrd, Ohio State University Comprehensive Cancer Centre, USA

Trial

Phase 2, ACE-CL-001, ASCEND

Conference

EHA 2020

9 September, 2020 12:19

Deep responses in R/R CLL with venetoclax monotherapy

Expert

Prof. Arnon Kater, Amsterdam University Medical Center, the Netherlands

Trial

Phase 3, VENICE 1

Conference

EHA 2020

9 September, 2020 11:35

MRD assessment post-CAR-T predicts ALL allo-HSCT bridging

Expert

Dr Hui Wang, Hebei Yanda Ludaopei Hospital, China

Conference

EHA 2020

9 September, 2020 11:02

Higher risk of severe COVID-19 seen in people with blood cancers

Journal

The Lancet Oncology

1 September, 2020 18:28

Venetoclax + navitoclax promising for R/R ALL or LL

Presented By

Prof. Elias Jabbour , University of Texas MS Anderson Cancer Centre, USA

Trial

Phase 1

Conference

EHA 2020

28 August, 2020 12:23

Microbiome predicts B-ALL predisposition

Presented By

Dr Carolina Vincente-Dueñas, Institute of Biomedical Research of Salamanca, Spain

Conference

EHA 2020

28 August, 2020 12:15

Gemcitabine maintenance after first-line chemo prolongs PFS in malignant mesothelioma

Journal

Lancet Respiratory Medicine

5 February, 2021 17:32

No survival boost from ipilimumab-pembrolizumab combo in NSCLC

Journal

Journal of Clinical Oncology

4 February, 2021 17:19

Lung-cancer screening in at-risk never-smokers catches early disease

Journal

IASLC World Conference on Lung Cancer

3 February, 2021 19:16

Nivolumab boosts survival in relapsed malignant mesothelioma

Journal

IASLC World Conference on Lung Cancer

2 February, 2021 17:35

COVID has led to a drop in lung cancer diagnosis, more deaths

Conference

IASLC World Conference on Lung Cancer

2 February, 2021 00:23

Lung-cancer salvage surgery might help after TKI treatment

Journal

Lung Cancer

29 January, 2021 18:00

Merck KGaA, GSK suffer lung cancer drug setback

20 January, 2021 17:04

Invasive tests prompted by cancer screening show high real-world complication rate

Journal

JAMA Network Open

1 January, 2021 18:08

Mouth bacteria linked to lung-cancer risk in never smokers

Journal

Thorax

1 January, 2021 18:01

One in eight lung-cancer patients have never smoked cigarettes

Journal

JAMA Oncology

25 December, 2020 19:57

Radiologists seem to agree with guidelines for lung-nodule evaluation

Journal

Journal of the American College of Radiology

8 December, 2020 18:18

Preoperative immunotherapy in early stage NSCLC safe and feasible

Conference

ESMO 2020

25 November, 2020 15:07

No advantage of post-operative radiotherapy in patients with stage IIIA N2 NSCLC

Conference

ESMO 2020

25 November, 2020 15:06

Adjuvant osimertinib in NSCLC reduces risk of CNS recurrence

Conference

ESMO 2020

25 November, 2020 15:05

Lorlatinib outperforms crizotinib in ALK-positive advanced NSCLC

Conference

ESMO 2020

25 November, 2020 15:02

First-line immune checkpoint inhibition in metastatic NSCLC

Conference

ESMO 2020

25 November, 2020 15:00

PD-L1 density, a new predictive biomarker in NSCLC

Conference

ESMO 2020

25 November, 2020 14:59

Atezolizumab/bevacizumab for non-squamous NSCLC with high PD-L1 expression

Conference

ESMO 2020

25 November, 2020 14:58

Consolidation ipilimumab and nivolumab in limited stage SCLC

Conference

ESMO 2020

25 November, 2020 14:56

Bispecific antibodies targeting PD-1 and CTLA-4: new kids on the block(ade)

25 November, 2020 12:45

Best treatment of extensive-stage lung cancer includes PD-L1 inhibitor and etoposide

Journal

JAMA Network Open

20 November, 2020 16:36

Lorlatinib surpasses crizotinib as first-line treatment for advanced ALK+ lung cancer

Journal

New England Journal of Medicine

18 November, 2020 23:11

Adverse events with checkpoint inhibitors tied to lung-cancer survival

Journal

JAMA Oncology

10 November, 2020 19:17

MRI may best CT for assessing mesothelioma tumor volume

Journal

Lung Cancer

6 November, 2020 18:46

Lung cancer screening: Most patients not eligible 1-2 years prior to diagnosis

Presented By

Dr Kiran Desai, Barking, Havering and Redbridge University Hospitals, UK

Conference

ERS 2020

29 October, 2020 19:43

Biomarkers: a novel tool to improve lung nodule classification

Presented By

Dr Michael Pritchett

Trial

PANOPTIC, ORACLE

Conference

ERS 2020

29 October, 2020 19:40

Distinct changes in lung microbiome precede clinical diagnosis of lung cancer

Presented By

Ms Erin Marshall, University of British Columbia, Canada

Conference

ERS 2020

29 October, 2020 19:30

Social smoking: Do not underestimate the risks

Presented By

Dr Pallavi Balte, Columbia University, USA

Conference

ERS 2020

29 October, 2020 19:04

Bristol Myers’ Opdivo succeeds in late-stage lung cancer trial

7 October, 2020 19:06

Atezolizumab results show benefit for selected NSCLC patients

Journal

New England Journal of Medicine

30 September, 2020 23:28

Amgen drug shrinks tumors in lung cancer patients with KRAS gene mutation -study

Journal

New England Journal of Medicine

21 September, 2020 16:25

AstraZeneca says Tagrisso shown to slow lung cancer spreading to brain

Journal

New England Journal of Medicine

21 September, 2020 16:20

Eosinophil count tied to immunotherapy’s efficacy, adverse effects in lung cancer

Journal

Lung Cancer

8 September, 2020 19:37

Higher thrombotic risk in NSCLC patient with ALK rearrangement

Presented By

Dr Hanny Al-Samkari, Massachusetts General Hospital, USA

Conference

ISTH 2020

8 September, 2020 14:41

ES-SCLC: tremelimumab + durvalumab + chemotherapy misses endpoint

Presented By

Prof. Luis G. Paz-Ares, Hospital 12 de Octubre, Spain

Trial

Phase 3, CASPIAN

Conference

ASCO 2020

8 September, 2020 13:50

Adjuvant osimertinib in NSCLC: practice changing ADAURA trial

Presented By

Prof. Roy S. Herbst, Yale Cancer Center, USA

Trial

Phase 3, ADAURA

Conference

ASCO 2020

8 September, 2020 13:39

ES-SCLC: pembrolizumab KEYNOTE-604 data

Presented By

Dr Charles M. Rudin, Memorial Sloan Kettering Cancer Center, USA

Trial

Phase 3, KEYNOTE-604

Conference

ASCO 2020

8 September, 2020 13:20

Second-line gemcitabine plus ramucirumab significantly improves overall survival

Presented By

Dr Maria Pagano, General Hospital Arcispedale Santa Maria Nuova, Italy

Trial

Phase 2, RAMES

Conference

ASCO20

8 September, 2020 13:17

Tiragolumab and atezolizumab: ORR in NSCLC

Presented By

Dr Delvys Rodriguez-Abreu, NYU Perlmutter Cancer Center, USA

Trial

Phase 2, CITYSCAPE

Conference

ASCO 2020

8 September, 2020 13:15

MET-amplified advanced NSCLC responds well to MET inhibitor capmatinib

Presented By

Prof. Jürgen Wolf, University Hospital Cologne, Germany

Trial

Phase 2, GEOMETRY

Conference

ASCO 2020

8 September, 2020 13:07

Higher thrombotic risk in NSCLC patient with ALK rearrangement

4 September, 2020 22:26

Letter from the Editor

4 September, 2020 22:26

Neural network identifies high-risk smokers for lung-cancer screening

Journal

Annals of Internal Medicine

1 September, 2020 18:25

Letter from the Editor

20 August, 2020 12:48

Letter from the Editor

12 August, 2020 10:43

MET-amplified advanced NSCLC responds well to MET inhibitor capmatinib

3 August, 2020 10:26

Tiragolumab and atezolizumab: ORR in NSCLC

3 August, 2020 10:23

Second-line gemcitabine plus ramucirumab significantly improves overall survival

3 August, 2020 10:22

ES-SCLC: pembrolizumab KEYNOTE-604 data

3 August, 2020 10:21

Adjuvant osimertinib in NSCLC: practice changing ADAURA trial

3 August, 2020 10:19

ES-SCLC: tremelimumab + durvalumab + chemotherapy misses endpoint

3 August, 2020 10:14

Letter from the Editor

3 August, 2020 10:03

Thoracic cancers versus COVID-19

31 July, 2020 09:55

Letter from the Editor

17 July, 2020 08:33

Higher thrombotic risk in NSCLC patient with ALK rearrangement

15 July, 2020 11:14

Tiragolumab and atezolizumab: ORR in NSCLC

3 June, 2020 08:40

ES-SCLC: pembrolizumab KEYNOTE-604 data

3 June, 2020 08:36

Thoracic cancers versus COVID-19

3 June, 2020 08:31

ES-SCLC: tremelimumab + durvalumab + chemotherapy misses endpoint

2 June, 2020 07:41

Adjuvant osimertinib in NSCLC: practice changing ADAURA trial

29 May, 2020 12:07

Letter from the Editor

18 May, 2020 10:16

Letter from the Editor

15 April, 2020 09:56

Letter from the Editor

23 September, 2019 14:45

Pembrolizumab quadruples survival in selected advanced non-small cell lung cancer patients

3 June, 2019 10:41

Comprehensive profiling in localised stage lung cancer

11 April, 2019 09:04

Prognostic value of distant organ-specific metastases in newly diagnosed lung neuroendocrine tumours

24 December, 2018 11:57

Spread through air spaces is prognostic in lung neuroendocrine tumours

24 December, 2018 11:55

Small-cell lung cancer circulating tumour cell derived explants

24 December, 2018 11:54

Avelumab vs docetaxel for previously treated advanced non-small-cell lung cancer

24 December, 2018 11:43

Patient-reported outcomes of first-line nivolumab + ipilimumab in high tumour mutational burden advanced non-small-cell lung cancer

24 December, 2018 11:41

Unmet needs in surgical management of malignant pleural mesothelioma

24 December, 2018 11:34

Crizotinib-treated ALK IHC-positive advanced NSCLC is associated with an unfavourable prognosis when FISH negative

24 December, 2018 11:31

No progression-free survival benefit with nintedanib plus pemetrexed/cisplatin for malignant pleural mesothelioma of epithelial subtype

24 December, 2018 11:11

Combination therapies: Where are we in 2018?

19 December, 2018 11:56

Next generation immunotherapy in non-small-cell lung cancer

19 December, 2018 11:54

Durvalumab after chemoradiotherapy extends OS in stage 3, unresectable non-small-cell lung cancer

19 December, 2018 11:46